# Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT

Study · id `cardio:ct-nct06498323` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06498323](<https://clinicaltrials.gov/study/NCT06498323>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06498323

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

## Technical summary

Registry record NCT06498323. Randomized; single masking; primary purpose treatment. Start 2022-08-03 (actual); primary completion 2025-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT06498323, source copy `cardio:ctgov-nct06498323-2024-07-12`, retrieved 2026-10-26)
- Started: 2022-08-03 (actual) (ClinicalTrials.gov record NCT06498323, source copy `cardio:ctgov-nct06498323-2024-07-12`, retrieved 2026-10-26)
- Primary completion: 2025-08-31 (anticipated) (ClinicalTrials.gov record NCT06498323, source copy `cardio:ctgov-nct06498323-2024-07-12`, retrieved 2026-10-26)
- Completion: 2025-08-31 (anticipated) (ClinicalTrials.gov record NCT06498323, source copy `cardio:ctgov-nct06498323-2024-07-12`, retrieved 2026-10-26)
- Countries: Thailand (ClinicalTrials.gov record NCT06498323, source copy `cardio:ctgov-nct06498323-2024-07-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06498323-2024-07-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT
- Condition: Intravenous
- Condition: Thrombosis
- Condition: Acute Ischemic Stroke
- Intervention (Drug): tenecteplase
- Lead sponsor: Mahidol University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry intervention is a member of this class by a sourced record link: Fibrinolytic (clot-dissolving) drugs (`cardio:fibrinolytic-clot-dissolving-drugs`)
- Registry lists this organization as the lead sponsor: Mahidol University (`cardio:org-mahidol-university`)

## Provenance

Content hash: c08869acf2d03e93ca47c2124babf29dcf83bdd608c4f86d17067438cbe0ad22
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
